DESIGN. OPTIMIZE. DELIVER. (U.S. Trademark Serial Number 85324610) is a United States trademark of BioCryst Pharmaceuticals, Inc.. The goods and services include: Pharmaceutical research and drug development; medical and scientific research, namely conducting clinical trials; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological and autoimmune diseases and disorders; development of pharmaceuticals for the treatment of influenza, hepatitis, AIDS, SARS, and West Nile virus; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphoma . The correspondent is Erica L. Han of Ropes & Gray LLP.

This trademark was filed on May 19, 2011 as United States Trademark Application Serial Number 85324610. The trademark application was registered on December 20, 2011 as U.S. Trademark Registration 4074214.

Trademark PTO Status History

July 01, 2022 – CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9

July 21, 2021 – TEAS CHANGE OF CORRESPONDENCE RECEIVED

July 21, 2021 – ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

July 21, 2021 – TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 06, 2021 – TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 06, 2021 – ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 06, 2021 – TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

April 16, 2021 – APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

View full trademark status information at USPTO

Ownership History

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc.

View documents on file at USPTO

File a Trademark or Get Help With Trademark Law

Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.